Linklaters is advising Takeda Pharmaceutical Company Limited (“Takeda”) in relation to its recommended offer for Shire plc (“Shire”) which values Shire at £46bn. The transaction was announced on 8 May 2018.

The Linklaters team is led by Corporate partner James Inglis, and includes Global Chairman of Corporate Matthew Middleditch and Corporate partners Aisling Zarraga, Tom Shropshire and Hiroya Yamazaki, Banking partners Danelle Le Cren and Ian Callaghan and Antitrust partners Jonas Kopenen and Tom McGrath.